Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 1
1980 3
1981 9
1982 12
1983 6
1984 10
1985 21
1986 18
1987 17
1988 18
1989 9
1990 11
1991 11
1992 12
1993 21
1994 19
1995 9
1996 25
1997 17
1998 18
1999 34
2000 22
2001 31
2002 46
2003 38
2004 35
2005 38
2006 37
2007 37
2008 47
2009 32
2010 37
2011 32
2012 42
2013 42
2014 52
2015 54
2016 39
2017 41
2018 44
2019 37
2020 28
2021 31
2022 24
2023 28
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

1,136 results

Results by year

Filters applied: . Clear all
Page 1
Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, Tayyari F, McSkimming D, Kannan N, Tojo A, Edison AS, Ito T. Hattori A, et al. Among authors: tojo a. Nature. 2017 May 25;545(7655):500-504. doi: 10.1038/nature22314. Epub 2017 May 17. Nature. 2017. PMID: 28514443 Free PMC article.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y, Uchimaru K. Yamagishi M, et al. Among authors: tojo a. Nature. 2024 Mar;627(8002):221-228. doi: 10.1038/s41586-024-07103-x. Epub 2024 Feb 21. Nature. 2024. PMID: 38383791 Free PMC article.
Here we show the potency and mechanisms of action and resistance of the EZH1-EZH2 dual inhibitor valemetostat in clinical trials of patients with adult T cell leukaemia/lymphoma. Administration of valemetostat reduced tumour size and demonstrated durable clinical response …
Here we show the potency and mechanisms of action and resistance of the EZH1-EZH2 dual inhibitor valemetostat in clinical trials of patients …
Updates on HTLV-1 Uveitis.
Kamoi K, Watanabe T, Uchimaru K, Okayama A, Kato S, Kawamata T, Kurozumi-Karube H, Horiguchi N, Zong Y, Yamano Y, Hamaguchi I, Nannya Y, Tojo A, Ohno-Matsui K. Kamoi K, et al. Among authors: tojo a. Viruses. 2022 Apr 12;14(4):794. doi: 10.3390/v14040794. Viruses. 2022. PMID: 35458524 Free PMC article. Review.
Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM). ...
Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that o …
Single-cell transcriptomics of human gut T cells identifies cytotoxic CD4(+)CD8A(+) T cells related to mouse CD4 cytotoxic T cells.
Tanemoto S, Sujino T, Miyamoto K, Moody J, Yoshimatsu Y, Ando Y, Koya I, Harada Y, Tojo AO, Ono K, Hayashi Y, Takabayashi K, Okabayashi K, Teratani T, Mikami Y, Nakamoto N, Hosoe N, Ogata H, Hon CC, Shin JW, Kanai T. Tanemoto S, et al. Among authors: tojo ao. Front Immunol. 2022 Oct 24;13:977117. doi: 10.3389/fimmu.2022.977117. eCollection 2022. Front Immunol. 2022. PMID: 36353619 Free PMC article.
The population of cytotoxic CD4(+) T cells in the human intestine is currently unknown. Moreover, it is unclear how cytotoxic CD4 T cells change in patients with inflammatory bowel disease (IBD). ...In CD4(+) T cells, granzyme and perforin expression was high …
The population of cytotoxic CD4(+) T cells in the human intestine is currently unknown. Moreover, it is unclear how cytotoxic CD4 …
GPR55: a new promising target for metabolism?
Tudurí E, Imbernon M, Hernández-Bautista RJ, Tojo M, Fernø J, Diéguez C, Nogueiras R. Tudurí E, et al. Among authors: tojo m. J Mol Endocrinol. 2017 Apr;58(3):R191-R202. doi: 10.1530/JME-16-0253. Epub 2017 Feb 14. J Mol Endocrinol. 2017. PMID: 28196832 Review.
Taxonomic revision of the Typhula ishikariensis complex.
Hoshino T, Tkachenko OB, Tojo M, Tronsmo AM, Kasuya T, Matsumoto N. Hoshino T, et al. Among authors: tojo m. Mycoscience. 2022 May 31;63(3):118-130. doi: 10.47371/mycosci.2022.03.003. eCollection 2022. Mycoscience. 2022. PMID: 37089628 Free PMC article.
Typhula ishikariensis and the related fungi were separated into three biological species by morphological and physiological characteristics, as well as DNA sequences and mating reactions. We propose that the T. ishikariensis complex should be divided into three species ( …
Typhula ishikariensis and the related fungi were separated into three biological species by morphological and physiological characteristics, …
NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies.
Shimizu K, Iyoda T, Yamasaki S, Kadowaki N, Tojo A, Fujii AS. Shimizu K, et al. Among authors: tojo a. Cancers (Basel). 2020 Mar 28;12(4):817. doi: 10.3390/cancers12040817. Cancers (Basel). 2020. PMID: 32231116 Free PMC article. Review.
Recent cancer treatment modalities have been intensively focused on immunotherapy. The success of chimeric antigen receptor T cell therapy for treatment of refractory B cell acute lymphoblastic leukemia has pushed forward research on hematological malignancies. ...Therefor …
Recent cancer treatment modalities have been intensively focused on immunotherapy. The success of chimeric antigen receptor T cell th …
Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrier.
Ishigaki T, Isobe M, Kobayashi S, Yuji K, Ohno N, Watanabe N, Tojo A, Uchimaru K. Ishigaki T, et al. Among authors: tojo a. Int J Hematol. 2013 May;97(5):667-72. doi: 10.1007/s12185-013-1314-z. Epub 2013 Apr 9. Int J Hematol. 2013. PMID: 23568283 Review.
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) after a long latency period of about 60 years. ...However, not all T-cell neoplasms that develop in HTLV-1-infected cases are ATL. ...
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) after a long latency period of about 60 years. …
Horizontal transmission of HTLV-1 causing uveitis.
Kamoi K, Horiguchi N, Kurozumi-Karube H, Hamaguchi I, Yamano Y, Uchimaru K, Tojo A, Watanabe T, Ohno-Matsui K. Kamoi K, et al. Among authors: tojo a. Lancet Infect Dis. 2021 Apr;21(4):578. doi: 10.1016/S1473-3099(21)00063-3. Lancet Infect Dis. 2021. PMID: 33773136 No abstract available.
Structural analysis reveals TLR7 dynamics underlying antagonism.
Tojo S, Zhang Z, Matsui H, Tahara M, Ikeguchi M, Kochi M, Kamada M, Shigematsu H, Tsutsumi A, Adachi N, Shibata T, Yamamoto M, Kikkawa M, Senda T, Isobe Y, Ohto U, Shimizu T. Tojo S, et al. Nat Commun. 2020 Oct 15;11(1):5204. doi: 10.1038/s41467-020-19025-z. Nat Commun. 2020. PMID: 33060576 Free PMC article.
1,136 results